Australia markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.5672-0.0242 (-4.08%)
At close: 06:34PM GMT
Full screen
Previous close0.5914
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.5611 - 0.6049
52-week range0.4477 - 2.9220
Avg. volume54,264
Market cap517,623
Beta (5Y monthly)1.64
PE ratio (TTM)N/A
EPS (TTM)-2.0560
Earnings date26 Feb 2024 - 01 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Better Growth Stock: CRISPR Therapeutics vs. Invitae

    Now is a great time to load up on growth stocks because they may be among the first to benefit in the next bull market. You'll find a lot of these candidates in the area of biotech, and two possibilities that come to mind right now are gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) and genetic-testing specialist Invitae (NYSE: NVTA). Which is the better growth stock to buy now?

  • Insider Monkey

    Invitae Corporation (NYSE:NVTA) Q3 2023 Earnings Call Transcript

    Invitae Corporation (NYSE:NVTA) Q3 2023 Earnings Call Transcript November 8, 2023 Invitae Corporation beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.3. Operator: Good afternoon, and welcome to the Invitae Third Quarter 2023 Financial Results Conference Call. My name is Carla and I will be your operator for today’s call. We will have a […]

  • Thomson Reuters StreetEvents

    Q3 2023 Invitae Corp Earnings Call

    Q3 2023 Invitae Corp Earnings Call